Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc. V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health.


TSXV:AVCR - Post by User

Bullboard Posts
Post by kingposton Jan 12, 2015 10:28pm
237 Views
Post# 23311987

marketing strategy note:

marketing strategy note:I was thinking about NPH;s Canadian marketing today and had this thought: I really like the idea of nph being the independent focused pharmacy supplier (and even staying away from the larger chains as a potential company policy).  I see a few nice benefits. Firstly, since  NPH would have a completely seperate channel from the national chains I think it would be easier  to get deals with newly developed generic drugs (and in case you did not know these ohave big advantages , profit wise, since there is a period of exclusivity of 6 monthes of the first generic out, and often it can be over a year or two before the secondt generic comes out, and often the first generic will sell for 70% of the brand for the first year  or two or even longer)..... so by having a seperate chanell from the major chains some generic drug developement companies  might give the Canadian market to two companies (NPH, for the independents and seperately to the national chains) ..if nph was selling in both channels it likely would be harder, initially especially, to land those deals..do not kid yourself this niche, within the generics space, is big potential growth and large sales...A last  related thought is that it will help enormously in getting these cherry picked new generics rights, by having our 48 molecule portfolio , of tradional generics, rolled out and underway...The other benefit of focusing on the independents is the  marketing program can be tailored to them alone, to make them feel special and cater exclusively to them...
Bullboard Posts